China Pharma Holdings (CPHI) EV to CFO (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly EV to CFO came in at 805.4 in Q2 2026, down 4337.19% on a YoY basis from 19.01 in Q2 2025, and down 188.29% quarter-over-quarter from 279.38 in Q1 2026.
Powered by 
Analysis
China Pharma Holdings (CPHI) EV to CFO (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has reported EV to CFO for 17 consecutive years, with 805.4 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EV to CFO fell 4337.19% year-over-year to 805.4; the trailing twelve-month figure through Jun 2026 stood at 188.2 (down 1733.1% YoY), and the FY2025 full-year result was 32.7, up 486.68% from the prior year.
- EV to CFO retreated to 805.4 in Q2 2026 per CPHI's latest filing, from 279.38 in the prior quarter.
- Across five years, EV to CFO topped out at 31.89 in Q4 2025 and bottomed at 805.4 in Q2 2026.
- Historically, EV to CFO has averaged 75.24 across 5 years, with a median of 13.17 in 2022.
- The sharpest annual moves came in 2024 and 2025: EV to CFO slumped 12915.93% in 2024, then surged 177.53% in 2025.
- Over 5 years, EV to CFO stood at 5.15 in 2022, then plunged by 641.98% to 27.92 in 2023, then jumped by 141.16% to 11.49 in 2024, then soared by 177.53% to 31.89 in 2025, then tumbled by 2625.27% to 805.4 in 2026.
- According to Business Quant data, EV to CFO over the past three periods registered 805.4, 279.38, and 31.89 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | China Pharma Holdings | 31.39 Mn | 31.08 Mn | 83,566.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -805.40 |
| Mar 31, 2026 | -279.38 |
| Dec 31, 2025 | 31.89 |
| Sep 30, 2025 | -35.50 |
| Jun 30, 2025 | 19.01 |
| Mar 31, 2025 | -110.88 |
| Dec 31, 2024 | 11.49 |
| Sep 30, 2024 | -74.58 |
| Jun 30, 2024 | -48.48 |
| Mar 31, 2024 | -7.96 |
| Dec 31, 2023 | -27.92 |
| Sep 30, 2023 | 0.58 |
| Jun 30, 2023 | -9.15 |
| Mar 31, 2023 | -1.45 |
| Dec 31, 2022 | 5.15 |
| Sep 30, 2022 | 20.35 |
| Jun 30, 2022 | -24.97 |
| Mar 31, 2022 | -17.20 |
| Dec 31, 2021 | -90.79 |
| Sep 30, 2021 | -57.53 |